CIK: 1437435 - Address: C/o Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080
40 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
P%ret11113622267416254
P%wins100100100100100100100
S%ret114-13-19784
S%wins75255050255046

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
11/28/22 19:30
11/23/22
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagTessier-Lavigne MarcCADS-61030.480-20-12,107D
11/3/22 17:37
11/1/22
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagTessier-Lavigne MarcCADS.m-60530.270-20-12,127D
10/3/22 16:05
9/29/22
REGNRegeneron Pharmaceuticals, Inc.NYHealthDrugPharmaceutical PreparationsTessier-Lavigne MarcNYDM.dm4,480413.330112D
10/3/22 16:05
9/29/22
REGNRegeneron Pharmaceuticals, Inc.NYHealthDrugPharmaceutical PreparationsTessier-Lavigne MarcNYDS.dm-7,611702.240-11-832D
9/30/22 16:50
9/28/22
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagTessier-Lavigne MarcCADS-61630.820-20-12,147D
8/25/22 18:11
8/23/22
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagTessier-Lavigne MarcCADS-63231.610-20-12,167D
7/27/22 18:49
7/25/22
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagTessier-Lavigne MarcCADS-71235.610-20-12,187D
6/28/22 15:07
3/23/22
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagTessier-Lavigne MarcCADS.a-67733.830-20-12,261D
3/25/22 17:57
3/23/22
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagTessier-Lavigne MarcCADS-67733.830-20-12,261D
3/23/22 16:01
3/21/22
REGNRegeneron Pharmaceuticals, Inc.NYHealthDrugPharmaceutical PreparationsTessier-Lavigne MarcNYDM.d2,834380.95072D
3/23/22 16:01
3/21/22
REGNRegeneron Pharmaceuticals, Inc.NYHealthDrugPharmaceutical PreparationsTessier-Lavigne MarcNYDS.d-5,133690.000-7-772D
3/18/22 16:05
3/16/22
REGNRegeneron Pharmaceuticals, Inc.NYHealthDrugPharmaceutical PreparationsTessier-Lavigne MarcNYDM.dm4,581375.770122D
3/18/22 16:05
3/16/22
REGNRegeneron Pharmaceuticals, Inc.NYHealthDrugPharmaceutical PreparationsTessier-Lavigne MarcNYDS.dm-8,268678.210-12-842D
12/30/21 21:59
12/28/21
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagTessier-Lavigne MarcCADS.m-2,80544.430-63-22,481M
12/10/21 17:41
12/9/21
REGNRegeneron Pharmaceuticals, Inc.NYHealthDrugPharmaceutical PreparationsTessier-Lavigne MarcNYDM.d1,405371.40042D
12/10/21 17:41
12/9/21
REGNRegeneron Pharmaceuticals, Inc.NYHealthDrugPharmaceutical PreparationsTessier-Lavigne MarcNYDS.d-2,516665.000-4-652D
9/15/21 16:02
9/13/21
REGNRegeneron Pharmaceuticals, Inc.NYHealthDrugPharmaceutical PreparationsTessier-Lavigne MarcNYDM.d3,489273.670132D
9/15/21 16:02
9/13/21
REGNRegeneron Pharmaceuticals, Inc.NYHealthDrugPharmaceutical PreparationsTessier-Lavigne MarcNYDS.d-8,182641.710-13-862D
6/8/21 17:10
6/7/21
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagTessier-Lavigne MarcCADM.d1,76518.7009442,544D
6/8/21 17:10
6/7/21
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagTessier-Lavigne MarcCADS.d-6,64070.350-94-42,544D
5/24/21 20:05
5/21/21
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagTessier-Lavigne MarcCADS.m-2,81160.110-47-22,542D
5/5/21 16:14
5/3/21
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagTessier-Lavigne MarcCADS-19560.110-302,589D
4/5/21 16:10
4/1/21
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagTessier-Lavigne MarcCADS-2,83156.620-50-22,592D
3/3/21 16:20
3/1/21
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagTessier-Lavigne MarcCADS-6,62266.220-100-42,642D
6/18/20 21:41
6/16/20
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagTessier-Lavigne MarcCADS-10,44026.100-400-132,739D
5/8/20 16:03
5/6/20
REGNRegeneron Pharmaceuticals, Inc.NYHealthDrugPharmaceutical PreparationsTessier-Lavigne MarcNYDM.d2,667177.820152D
5/8/20 16:03
5/6/20
REGNRegeneron Pharmaceuticals, Inc.NYHealthDrugPharmaceutical PreparationsTessier-Lavigne MarcNYDS.d-8,459563.970-15-892D
2/14/20 16:10
2/13/20
REGNRegeneron Pharmaceuticals, Inc.NYHealthDrugPharmaceutical PreparationsTessier-Lavigne MarcNYDM.d75853.080142D
2/14/20 16:10
2/13/20
REGNRegeneron Pharmaceuticals, Inc.NYHealthDrugPharmaceutical PreparationsTessier-Lavigne MarcNYDS.d-5,712400.010-14-892D
8/5/15 20:55
8/5/15
REGNRegeneron Pharmaceuticals IncNYHealthDrugPharmaceutical PreparationsTessier-Lavigne MarcNYDM.d28657.113351D11379422511776-2-4-13-2-29-26
8/5/15 20:55
8/5/15
REGNRegeneron Pharmaceuticals IncNYHealthDrugPharmaceutical PreparationsTessier-Lavigne MarcNYDS.d-2,951590.2633-5-811D11379422511776-2-4-13-2-29-26
2/27/15 16:32
2/26/15
REGNRegeneron Pharmaceuticals IncNYHealthDrugPharmaceutical PreparationsTessier-Lavigne MarcNYDM.d15350.913331D16025192414-114102329-5
2/27/15 16:32
2/26/15
REGNRegeneron Pharmaceuticals IncNYHealthDrugPharmaceutical PreparationsTessier-Lavigne MarcNYDS.d-1,266421.9633-3-721D16025192414-114102329-5
8/27/14 17:02
8/26/14
REGNRegeneron Pharmaceuticals IncNYHealthDrugPharmaceutical PreparationsTessier-Lavigne MarcNYDM.dm22350.913341D1554551616424-132172052
8/27/14 17:02
8/27/14
REGNRegeneron Pharmaceuticals IncNYHealthDrugPharmaceutical PreparationsTessier-Lavigne MarcNYDS.d-1,057352.2033-3-721D1554551616424-132172052
4/3/14 17:43
7/24/13
AGIOAgios Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsTessier-Lavigne MarcMADP1,00018.002156122101D275312-17-2-1136222674162
5/8/13 17:52
5/6/13
REGNRegeneron Pharmaceuticals IncNYHealthDrugPharmaceutical PreparationsTessier-Lavigne MarcNYDM.d71053.2333130D4469683545423215-17-4-479
5/8/13 17:52
5/6/13
REGNRegeneron Pharmaceuticals IncNYHealthDrugPharmaceutical PreparationsTessier-Lavigne MarcNYDS.d-3,479260.9133-13-1000D4469683545423215-17-4-479
7/18/08 12:33
7/16/08
DNAGenentech IncDEHealthDrugPharmaceutical PreparationsTessier-Lavigne MarcCAOEVP,RESEM.d99853.230191D
7/18/08 12:33
7/16/08
DNAGenentech IncDEHealthDrugPharmaceutical PreparationsTessier-Lavigne MarcCAOEVP,RESES.d-1,49879.900-19-941D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact